Schedule 13G ownership disclosure

VYNE THERAPEUTICS INC

Security class unavailable · CUSIP: 92941V308

Event date: 2023-11-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-117288
Form type
SC 13G
Filer
CITADEL ADVISORS LLC
CIK
CIK 1423053
Filed
Nov 13, 2023
Reporting period
Nov 01, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub